Clinical Neuropsychology: Open Access
Open Access
Adverse drug events (ADE)
Search results for
Adverse drug events (ADE)
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 141
Clinical Neuropsychology: Open Access received 141 citations as per Google Scholar report
Indexed In
- Google Scholar
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
Useful Links
Recommended Journals
Related Subjects
Share This Page
Adverse drug events (ADE)
An adverse drug event can be defined as an injury resulting from the use of a drug. In hospitals, an adverse drug event occurs as medication errors such as accidental overdose or providing a drug to the wrong patient or by adverse drug reactions, such as an allergic reaction. ADEs can occur in any health care ventures such as In-patient like acute care hospitals, Out-patient and Long-term care.
Journals Related To Adverse Drug Events
Journal of Pharmacovigilance, Clinical & Experimental Pharmacology, Adverse Drug Reaction Journals, Adverse Drug Reaction Bulletin, International MCH journal, Pharmaceutics Journal, Italian Journal of Pediatrics, The Canadian Journal of Hospital Pharmacy, American Journal of Health-System Pharmacy, Journal of Clinical Pharmacy and Therapeutics.
Adverse drug events (ADE)
Expert PPTs
- Wei Wang
Combating neglected tropical diseases
PPT Version | PDF Version - Srinivasan Shanmugam
Lipid Based Oral Drug Delivery System (LBODDS)
PPT Version | PDF Version - Vinayagam Kannan
Vinayagam_Kannan
PPT Version | PDF Version - Farnaz Monajjemzadeh
Farnaz Monajjemzadeh
PPT Version - Khosro Adibkia
Khosro Adibkia
PPT Version | PDF Version - Yazen M Alnouti
Yazen_M-Alnouti
PPT Version | PDF Version - Ioan Magyar
Introduction to Clinical Pharmacology
PPT Version | PDF Version - NAGENDRA SASTRY YARLA
Pharmacology
PPT Version | PDF Version - Zhen Yuan
Molecular imaging
PPT Version | PDF Version
Speaker PPTs
- Sundeep Kumar Upadhyaya
LONG TERM DRUG-FREE CLINICAL-REMISSION IN PATIENTS WITH RA ON cDMARDs
PPT Version | PDF Version - Li Yu-Jung
Intra-maxillary Drug delivery and Bio-sensing via Dental Implant and its considerations
PPT Version | PDF Version - Carsten Worsoe
The value of the ââ¬Åsimulated studyââ¬Â as a tool to predict actual leachables in parenteral drug products
PPT Version | PDF Version - Diane Paskiet
Qualifi cation of extractables & leachables from container closure systems in drug products- Introduction to the Product Quality Institute (PQRI) recommendations
PPT Version | PDF Version - Li-Chun Tsou
Drug delivery device strategy for patient centric therapies
| PDF Version - Neervalur V Raghavan
Systematic approach to development of aqueous drug formulation and drug device combination injectable products and challenges
PPT Version | PDF Version - Panayiotis P Constantinides
Parenteral Drug Nanodispersions : Manufacturing, Characterization and In Vitro/In Vivo Performance Evaluation
PPT Version | PDF Version - Jan Voskuil
How antibodies can prevent medical progress and how they can be great tools?
PPT Version | PDF Version - Arshad mahmood
TRANSPORT OF SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS) ACROSS MUCUS AND CELLULAR INTERNALIZATION
PPT Version | PDF Version - Hugo Albrecht
Towards pharmacological validation of MNKs as anti-cancer drug targets
PPT Version | PDF Version - Vivek Lal
New drug development in type-2 diabetes mellitus : current and future trends ââ¬â an overview
PPT Version | PDF Version - Joan Smith Sonneborn
Novel anti-retroviral drug targets: Interfering siRNA and mitochondrial TERT expression
PPT Version | PDF Version - Barbara Klajnert-Maculewicz
Sugar-modified PPI dendrimers as carriers of anti-leukemia drugs
PPT Version | PDF Version - Adel Nefzi
ââ¬ÅAdel Nefzi-Torrey-Pines-Institute-for-Molecular-Studies-USA-Diversity-Oriented-Synthesis-of-low-Molecular-Weight-Acyclic-and-Heterocyclic-Compounds-from-Resin-bound-Polyamides-Application-for-Drug-Discoveryââ¬Â
PPT Version | PDF Version - IIldikó Molnár
The role of IL-17A in postmenopausal inflammatory events, such as in osteoporosis
PPT Version | PDF Version - Tanvir Ahmed
Sexual partners and condom use attitude: Qualitative findings among injecting drug users in Hai Phong, Vietnam
PPT Version | PDF Version - Mukesh Kumar
Membrane fusion mediated cytosolic drug delivery through scFv targeted Sendai viral envelopes
PPT Version | PDF Version - Thomas J Franz
Assessing the BA and BE of Topical Dermatologic Drug Products with Multiple Surrogate Methods
PPT Version | PDF Version - Rinat Islamov
Pharmacokinetics (PK) of anti-tuberculosis drug (FS-1) on healthy volunteers: results from the phase I trial
PPT Version | PDF Version - Almas Okassov
Chemical modification of anticancer Parasporins for decreasing of their toxicity
PPT Version | PDF Version - Akujobi Comfort
Multi drug-resistant tuberculosis (MDR-TB) among HIV positive patients in a tertiary institution in south eastern Nigeria
PPT Version | PDF Version - Sevgi Gungor
Micelles as nanosized carriers for skin delivery of drugs
PPT Version | PDF Version - Ru Band Lu
Anti-Inflammation and neuroprotective drugs benefit the treatment of heroin dependent patients
PPT Version | PDF Version - Helmi Mardassi
A ten-year evolution of a multidrug-resistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia (2001-2011)
PPT Version | PDF Version - Sungchul Ji
Mathematical Models of RNA Expression Profiles: Potential Applications to Drug Discovery Research and Personalized Medicine
PPT Version | PDF Version - Anita Nair
BCS-Based Biowaivers: Which Drugs are Eligible?
PPT Version | PDF Version - Adriana Katz
Na,K-ATPase isoform-selective cardiac glycosides- a potential anti-cancer drug ?
PPT Version | PDF Version - Eggehard Holler
Biodegradable nanobrushes for drug delivery
PPT Version | PDF Version - Tao Lu
Using VBIM technique to identify drug resistance genes in ovarian cancer
PPT Version | PDF Version - Shlomit Schaal
Engineering an end to post-vitrectomy cataracts
PPT Version | PDF Version - Navneet Sharma
Transdermal patches based on solid lipid nanoparticles of Metformin: Novel approach for drug delivery of Type 2 diabetes
PPT Version | PDF Version - Viral Kansara
Ocular melanin modulates pharmacokinetics and drug disposition of therapeutic agents
PPT Version | PDF Version - Linda F. McElhiney
Preparing and obtaining quality compounded ophthalmic preparations
PPT Version | PDF Version - Richard A. Kenley
Equilibrium binding interactions between lotrafilcon a soft contact lenses and the two prostaglandin anti-glaucoma drugs Bimatoprost and Tafluprost
PPT Version | PDF Version - Elena Gavrilova
Application of drugs based on release-active antibodies as immunotherapy agents
PPT Version | PDF Version - William Lee
Regulatory roadmap for initiating a cell therapy drug into clinical trials in the US
PPT Version | PDF Version - Krasimira Pekova
Have FDA expedited programs really shortened drug review time? an analysis of newly approved therapies and how FDA expedited programs have impacted drug development timelines
PPT Version | PDF Version - Jasmin Kaur
Helping clinicians connect: Understanding addiction from the perspective of a drug abuser
PPT Version | PDF Version - Matin Peters
Cognitive-behavioral therapy as an effective treatment method in the ASEAN setting
PPT Version | PDF Version - Marcelo Febo
3,4-Methylenedioxypyrovalerone (MDPV), a major bath salt drug, reduces functional connectivity in rat brain
PPT Version | PDF Version - Maria Vittoria Barone
Lactobacillus paracasei CBA L74 prevents entrance of undigested gliadin peptides and rotavirus in Caco-2 cells
PPT Version | PDF Version - Jim Klostergaard
Magnetic vectoring for drug delivery to tumors: Past, present and is there a future?
PPT Version | PDF Version - Sree Harsha
Optimization of particles size for lung specific drug delivery by way of microspheres
PPT Version | PDF Version - Ruslan N. Grishanin
Adeno-associated virus-mediated delivery of amyloid ò antibody for treatment of age-related retinal degenerative diseases
PPT Version | PDF Version - Mauro Comes Franchini
Gold, silver magnesium and magnetic nanoparticles: Nanomedicine applications in drug delivery
PPT Version | PDF Version - W Wagner
Tumor regression by means of magnetic drug targeting
PPT Version | PDF Version - Arpitha Parthasarathy
A Coordinating Epithelial Cell Proliferation and Migration in Corneal Wound Healing
PPT Version | PDF Version - Jung-Joon Min
Bacteria-mediated expression of cargo drugs and reporter gene for cancer-specific theranostics
| PDF Version - Chris Lange-Kuettner
Does seeing in viewpoint perspective require awareness?
PPT Version | PDF Version - Maria Paola COSTI
A proteomic-bioinformatic integrated approach for studying the effect of a peptide drug candidate on ovarian Cancer
PPT Version | PDF Version - Vladimir Torchilin
Stimuli-sensitive combination nanopreparations of siRNA and chemotherapeutic drugs to treat multidrug resistant cancer
PPT Version | PDF Version - Oleksiy Buznyk
Past, present and future of artificial corneas: Ukraine experience
PPT Version | PDF Version - Vijaya Juturu
Soluble lutein (lutemax2020î) prevents retinal damage in streptozotocin (stz)-induced diabetic rats
PPT Version | PDF Version - Nicholas J. Butler
Interferon alpha-2b in the treatment of refractory uveitic cystoid macular edema
PPT Version | PDF Version - Baharudin Ibrahim
Personalizing drug treatment using pharmacometabonomic approach
| PDF Version - Beniamino Palmieri
An intriguing nutraceutical approach in dogs affected by Keratoconjunctivitis sicca
PPT Version | PDF Version - Shamim Ahmad
Honey: Clinical applications and scope as an alternate antibacterial therapy in multi- resistant ocular bacterial infections especially involving MRSA
PPT Version | PDF Version - Janardan Kumar
An overview of RGD-containing peptides research and itââ¬â¢s potentials to the field of glaucoma therapy and/or vitreolysis
PPT Version | PDF Version - Eugenia Poliakov
Long-term multiple A2E treatment leads to melanization of ARPE19 cells.
PPT Version | PDF Version - Ruben Artero
A Drosophila high-throughput drug screening platform identifies inhibitors of misregulated alternative splicing events in myotonic dystrophy
PPT Version | PDF Version - Vladimir E. Bondarenko
Mathematical model of ò1-adrenergic signaling in mouse ventricular myocytes as an in silico tool for the cardiovascular drug test
PPT Version | PDF Version - Maria ISAGULIANTS
DNA vaccination against drug resistance in chronic viral infections, example of HIV-1
PPT Version | PDF Version - Carlota Saldanha
Fibrinogen effects on erythrocyte nitric oxide mobilization in presence of timolol
| PDF Version - Miguel Rechichi
Corneal collagen crosslinking: Past, present and future of conservative treatment for keratoconus
PPT Version | PDF Version - Grace London
Development of aptamer based HIV-1 entry inhibitor prophylactic drugs
PPT Version | PDF Version - Aina Westrheim Ravna
Novel sildenafil analogues: possible drugs for increased sensitivity to chemotherapeutic agents
PPT Version | PDF Version